Document is current
Any future updates will be listed below
-
Authors
Alvarez-Fischer, Daniel
Borsche, Max
Balck, Alexander
Föh, Bandik
Hoischen, Arnim
Hotak, Fawad
Reinhardt, Jan
Elsner, Susanne A.
Peters, Elke
Rieck, Andrea
Martin, Emily L.
Künsting, Inga
Ehlers, Marc
Mischnik, Alexander
Taube, Stefan
Käding, Nadja
Rupp, Jan
Katalinic, Alexander
Klein, Christine
-
Funding
Funding for this research was provided by:
Universität zu Lübeck
- License Information
-
More Information
Article History
Received: 1 February 2023
Accepted: 27 February 2025
First Online: 7 April 2025
Declarations
:
: The ethics committee of the University of Lübeck approved the study (Az. 20–150). The research was conducted in accordance with the Declaration of Helsinki, confirming that all methods were carried out in accordance with relevant guidelines and regulations in the respective declaration. All participants gave written informed consent. All study materials were translated into the refugees’ native languages, and interpreters were available onsite at the study center.
: Not Applicable.
: CK serves as medical advisor to Centogene for genetic testing reports in the fields of movement disorders and dementia, excluding Parkinson’s disease, and serves on the Scientific Advisory Board of Retromer Therapeutics. DAF received consultancy fees as well as fees for lectures, workshops and brochures from Takeda Pharma GmbH and Medice Arzneimittel Pütter GmbH & Co KG in the last 12 months. Neither activity represents a conflict of interest. Likewise, none of the other authors declares any financial conflict of interest.
